NextGen Ventures

STENTiT is a company that specializes in the development of regenerative stents aimed at restoring arteries. Its primary focus is on creating biodegradable endovascular implants that promote a natural healing response in patients. These innovative stents facilitate the circulation of blood cells, which work to replace the implant with new vascular tissue, effectively restoring the artery from the inside. By offering these advanced medical solutions, STENTiT enables healthcare professionals to treat patients suffering from cardiovascular diseases more effectively.

EQUO creates a product that has minimal impact on the environment. It provides a variety of truly eco-friendly solutions for everyday items by providing products that are 100% natural, plastic-free, non-toxic, chemical-free & biodegradable, and compostable.

Developer of an intelligent data protection platform designed to prevent email data leaks. The company's platform allows communicating securely without disrupting the work processes, increases awareness to control data from being sent to the wrong person, and complies with regulations, enabling clients to reduce the risk of a data breach.

Manometric B.V., located in Delft, the Netherlands, specializes in the 3D printing of customized hand braces. The company develops innovative technology for orthotic and prosthetic instruments, utilizing a proprietary instant 3D hand scanner and advanced automation software. This enables orthopedic specialists to design and produce comfortable, aesthetically pleasing hand braces tailored to individual patient needs. By combining cutting-edge 3D software with unique design capabilities, Manometric facilitates the creation of personalized solutions for medical professionals, enhancing both functionality and patient comfort.

LeQuest B.V., founded in 2011 and based in Rotterdam, the Netherlands, specializes in e-training services for the healthcare industry. The company has developed a software platform that enables healthcare professionals to receive training on the use of complex medical equipment. This platform includes several modules that digitally reproduce medical devices and their functionalities. As the healthcare sector increasingly relies on advanced medical technology, LeQuest's software assists healthcare institutions in managing staff competencies and knowledge. The platform ensures that certification, registration, and retraining for specific medical equipment are systematically addressed, enhancing the overall proficiency of healthcare professionals.

Enpicom is a bioinformatics software engineering company that specializes in providing innovative solutions for scientists in biopharma and academic research. The company develops products aimed at enhancing the discovery and development of novel immunotherapies and vaccines. Enpicom's flagship offering is the ImmunoGenomiX (IGX) Platform, which facilitates the management, storage, analysis, visualization, and comparison of immune repertoire sequencing data from T and B cell receptors. By utilizing a combination of biological expertise, bioinformatics method development, and software engineering, Enpicom's technology-agnostic and code-free software simplifies the complexities associated with immune repertoire analysis. This enables researchers to concentrate on their scientific inquiries and advancements in antibody discovery, ultimately contributing to improved human health.

Plasmacure, located in Eindhoven, the Netherlands, focuses on developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. This innovative approach not only targets and eliminates bacteria but also promotes cell proliferation and enhances microcirculation. By addressing these critical factors, Plasmacure's technology helps healthcare professionals reduce the risk of amputation and improve the overall quality of life for patients suffering from chronic wounds.

Plasmacure, located in Eindhoven, the Netherlands, focuses on developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. This innovative approach not only targets and eliminates bacteria but also promotes cell proliferation and enhances microcirculation. By addressing these critical factors, Plasmacure's technology helps healthcare professionals reduce the risk of amputation and improve the overall quality of life for patients suffering from chronic wounds.

Everyday makes applications that you want to use every day. They believe that impact and success lie in connecting digitally with everyday things. More convenience in a process, more fun working or easier contact.

Plasmacure, located in Eindhoven, the Netherlands, focuses on developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. This innovative approach not only targets and eliminates bacteria but also promotes cell proliferation and enhances microcirculation. By addressing these critical factors, Plasmacure's technology helps healthcare professionals reduce the risk of amputation and improve the overall quality of life for patients suffering from chronic wounds.